This inventor holds 2 USPTO granted patents. Top assignees: Universitéde Liége, University De Liege. Active years: 2004-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Grivegnee, BE (2004)
- Grivegnée, BE (2007)
Company Filing History:
Years Active: 2004-2007
Title: Jean-Michel Dogne: Innovator in Pyridinic Sulfonamide Derivatives
Introduction
Jean-Michel Dogne is a notable inventor based in Grivegnée, Belgium. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pyridinic sulfonamide derivatives.
Latest Patents
Jean-Michel Dogne holds a patent for "Pyridinic sulfonamide derivatives method of production and use thereof." This patent describes new pyridinic sulfonamide derivatives represented by a general formula (I), wherein R1 represents a mono- or polyhalogenated C1–12-alkyl or a mono- or poly-halogenated C3–8-cycloalkyl group. The patent also details the method of production of these derivatives and their application as active therapeutic substances in treating diseases such as inflammation, arthrosis, cancer, angiogenesis, and asthma.
Career Highlights
Jean-Michel Dogne is affiliated with the University de Liège, where he continues to engage in research and development in the field of pharmaceuticals. His work has garnered attention for its potential impact on therapeutic treatments.
Collaborations
He has collaborated with notable colleagues, including Jacques Delarge and Bernard Pirotte, contributing to advancements in their shared field of expertise.
Conclusion
Jean-Michel Dogne's innovative work in pyridinic sulfonamide derivatives showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile